When I wrote about the rising shortage of ADHD drugs earlier this month, I felt like a failure for my inability to offer a clear explanation for what lies behind it. I ran into a sort of hall of mirrors, with conflicting accounts from federal officials and drug companies, some of it frustratingly off the record — and I threw up my hands, hoping some more investigative type with more time would ferret out the truth.
So I’m a little comforted that in his excellent report today for NPR on the national ADHD drug shortage, Dick Knox, a veteran health and science reporter whom I respect maximally, seems to have run into the same thing. He says that the ADHD drug Adderall has become hard to get in recent months “for reasons that are unclear.”
And in the Web version of his story, he writes, near the end, “For one version of what really may be going on behind the scenes to cause (or exacerbate) the shortages – or market distortions, as the DEA would have it – read this.”
“This” is a long and fascinating piece on “the fix,” a Website on addiction and recovery. It has “The Great American Adderall Drought” in the headline, and in the sub-head, “Naturally, it’s all about Big Pharma profits.”
Please forgive my prudishness, but I’m going to delete a profane gerund in this quote: Continue reading